Foghorn Therapeutics, Inc. (FHTX)
1.87
+0.02
(+1.08%)
USD |
NASDAQ |
Oct 19, 14:19
Foghorn Therapeutics Price : 1.87 for Oct. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.81 | 1.90 | 1.81 | 1.85 | 981305.0 |
| Oct 15, 2026 | 1.87 | 1.91 | 1.82 | 1.89 | 349343.0 |
| Oct 14, 2026 | 1.85 | 1.890 | 1.80 | 1.85 | 1.072M |
| Oct 13, 2026 | 1.945 | 1.95 | 1.84 | 1.85 | 851222.0 |
| Oct 12, 2026 | 1.98 | 2.00 | 1.94 | 1.95 | 586299.0 |
| Oct 09, 2026 | 1.96 | 2.081 | 1.945 | 2.00 | 646951.0 |
| Oct 08, 2026 | 2.05 | 2.14 | 1.885 | 1.99 | 1.228M |
| Oct 07, 2026 | 1.92 | 2.15 | 1.906 | 2.09 | 917105.0 |
| Oct 06, 2026 | 2.00 | 2.02 | 1.835 | 1.97 | 984693.0 |
| Oct 05, 2026 | 2.03 | 2.12 | 1.98 | 2.00 | 987959.0 |
| Oct 02, 2026 | 2.91 | 2.91 | 1.99 | 2.02 | 2.547M |
| Oct 01, 2026 | 2.08 | 3.21 | 1.79 | 2.92 | 13.38M |
| Sep 30, 2026 | 3.55 | 3.60 | 3.50 | 3.57 | 419958.0 |
| Sep 29, 2026 | 3.53 | 3.58 | 3.46 | 3.52 | 376220.0 |
| Sep 28, 2026 | 3.49 | 3.62 | 3.40 | 3.52 | 337374.0 |
| Sep 25, 2026 | 3.61 | 3.66 | 3.465 | 3.50 | 525425.0 |
| Sep 24, 2026 | 3.83 | 3.85 | 3.55 | 3.60 | 518520.0 |
| Sep 23, 2026 | 4.12 | 4.21 | 3.85 | 3.87 | 1.796M |
| Sep 22, 2026 | 4.21 | 4.32 | 4.15 | 4.24 | 328886.0 |
| Sep 21, 2026 | 4.16 | 4.19 | 4.07 | 4.15 | 188406.0 |
| Sep 18, 2026 | 4.21 | 4.25 | 4.07 | 4.14 | 502030.0 |
| Sep 17, 2026 | 4.27 | 4.324 | 4.13 | 4.20 | 246007.0 |
| Sep 16, 2026 | 4.17 | 4.23 | 4.08 | 4.17 | 354922.0 |
| Sep 15, 2026 | 4.35 | 4.380 | 4.09 | 4.12 | 467622.0 |
| Sep 14, 2026 | 4.415 | 4.56 | 4.33 | 4.36 | 399648.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 56.60 |
| Oncolytics Biotech, Inc. | 0.5033 |
| Sangamo Therapeutics, Inc. | 0.1102 |
| Sarepta Therapeutics, Inc. | 17.71 |
| Anixa Biosciences, Inc. | 2.66 |
Price Related Metrics
| PS Ratio | 3.307 |
| Earnings Yield | -54.62% |
| Market Cap | 109.80M |